xylazine has been researched along with mocetinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, AM; Chung, HS; Fessler, HE; Otterbein, L | 1 |
| Chen, JQ; Liang, YQ; Lu, JJ; Mao, LG; Tang, HF; Tang, JF; Wang, XF; Wang, YJ; Zheng, X | 1 |
2 other study(ies) available for xylazine and mocetinostat
| Article | Year |
|---|---|
Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Creatinine; Escherichia coli; Hemodynamics; Lipopolysaccharides; Lung; Male; Peroxidase; Quinoxalines; Rats; Rats, Sprague-Dawley; Survival Rate; Tumor Necrosis Factor-alpha; Xylazine; Yohimbine | 1996 |
Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Lung Injury; Anesthetics; Animals; Anti-Inflammatory Agents; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Cyclic Nucleotide Phosphodiesterases, Type 4; Dexamethasone; Furans; Intubation, Intratracheal; Ketamine; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Peroxidase; Phenyl Ethers; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Rolipram; Tumor Necrosis Factor-alpha; Xylazine | 2010 |